The government alleges that the Fort Worth cardiologist’s licenses in all 48 contiguous states enabled companies he owned to bill public and private insurers for cardiovascular examinations performed on student athletes at schools nationwide.
WASHINGTON, DC — Federal prosecutors accuse Doctor Jason Finkelstein of using an unusually extensive medical licensing footprint to transform a campus-based cardiovascular testing business into a nationwide billing operation that allegedly submitted more than eighty-nine million dollars in fraudulent insurance claims.
According to the government, Finkelstein maintained physician licenses in all 48 contiguous states, allowing companies under his ownership to associate his credentials with cardiovascular examinations performed on student athletes at schools far beyond his Texas medical practice.
The prosecution alleges those licenses became an essential operational bridge connecting traveling sonographers, campus testing contracts, electronic medical records, professional certifications, insurance submissions, and reimbursements distributed through businesses controlled by the Fort Worth cardiologist and his alleged collaborators.
Finkelstein has pleaded not guilty to conspiracy involving healthcare fraud and wire fraud, along with three substantive healthcare fraud counts, leaving every accusation concerning nationwide expansion, medical necessity, corporate control, test review, and insurance deception unresolved before trial.
Indictment connects licensing with national expansion
The federal indictment against Jason Finkelstein expressly alleges that his licenses across the 48 contiguous states enabled him and his alleged co-conspirators to submit claims involving students from schools located throughout the United States.
Rather than treating Finkelstein’s licensing history as incidental professional background, prosecutors have incorporated that extraordinary geographic reach into their description of how the alleged operation expanded beyond regional testing and accessed insurance benefits connected with athletes nationwide.
The government’s theory suggests that each additional state license increased the operation’s ability to present Finkelstein as an authorized ordering, referring, reviewing, or rendering physician when submitting claims arising from cardiovascular examinations conducted within that jurisdiction.
Defense attorneys may argue that obtaining multiple medical licenses is lawful, professionally legitimate, and increasingly practical for physicians providing telemedicine, remote interpretation, consulting, or specialized services across state boundaries in modern healthcare systems.
Possessing broad licensure cannot independently establish fraudulent intent, because prosecutors must prove that Finkelstein knowingly used those credentials to advance materially deceptive claims rather than merely demonstrating that his lawful qualifications supported a geographically diverse medical practice.
A nationwide credential created a scalable structure
The alleged business model depended upon bringing testing personnel and portable equipment directly to student athletes instead of requiring each participant to visit Finkelstein’s Texas office or establish a traditional clinical relationship through an individually scheduled appointment.
Prosecutors contend that this mobile structure allowed testing teams to serve concentrated groups of insured students at colleges and universities, generating substantial numbers of electrocardiograms, echocardiograms, vascular ultrasounds, and related cardiovascular records during organized campus visits.
Finkelstein’s multi-state licenses allegedly provided the physician-level authorization needed for companies to process those geographically dispersed examinations through centralized professional associations, turning localized campus encounters into claims directed to numerous public and commercial benefit programs.
Without a physician authorized within the relevant jurisdictions, the operation could have encountered significant barriers involving ordering authority, professional interpretation, insurer enrollment, claim eligibility, supervision requirements, and legal responsibility for medical services delivered across state boundaries.
The government therefore portrays the licensing portfolio as infrastructure that enabled expansion, while the defense can insist that infrastructure remains neutral unless prosecutors show how specific credentials were deliberately linked to particular false statements and charged transactions.
Schools provided concentrated access to insured athletes
College campuses offered the testing enterprise access to groups of young athletes whose eligibility, health concerns, family histories, and understandable fears about sudden cardiac arrest created a receptive environment for cardiovascular screening promoted as potentially lifesaving.
Prosecutors allege that company representatives approached athletic trainers and other school personnel with messages emphasizing the possibility that testing could identify serious cardiovascular conditions before an athlete collapsed during competition, training, or another physically demanding activity.
The government contends that some referral sources received checks, electronic transfers, gift cards, or other benefits associated with athlete participation, although each disputed payment must be evaluated individually before it can be characterized as an unlawful inducement.
Defense attorneys may examine whether schools independently requested services, evaluated clinical benefits, reviewed personnel qualifications, approved testing protocols, or received legitimate compensation for administrative work, facilities, scheduling assistance, and other responsibilities connected with campus programs.
Even if particular marketing or referral practices were improper, prosecutors must still connect Finkelstein personally to the alleged unlawful agreement rather than automatically attributing every decision made by marketers, technicians, administrators, and institutional representatives to him.
Standardized testing allegedly replaced individual diagnosis
Federal authorities allege that nearly every participating athlete received substantially the same six-test cardiovascular panel, despite important differences in symptoms, medical histories, family risk factors, prior examinations, athletic activities, ages, and clinical circumstances.
That repeated structure supports the government’s argument that the services represented generalized screening rather than individually justified diagnostic testing, although standardized protocols can possess legitimate preventive value when developed and administered according to appropriate professional standards.
Insurance eligibility is a separate question from clinical usefulness, because a service may benefit an athlete but remain uncovered unless documented symptoms, suspected conditions, physician findings, or other policy requirements establish medical necessity.
Prosecutors claim that Finkelstein did not personally examine the athletes before becoming identified as the ordering or referring physician, creating questions about what individualized information could have supported the diagnostic procedures subsequently billed under his professional authority.
The defense may identify questionnaires, remote assessments, standing protocols, trainer observations, medical histories, preliminary reviews, or communications that contributed to clinical decision-making, although their sufficiency will depend upon the evidence and applicable payer requirements.
False diagnoses allegedly opened reimbursement pathways
The indictment alleges that claims contained diagnoses such as hypertension, elevated blood pressure, or comparable medical conditions that the student athletes did not actually possess, thereby making standardized screening appear eligible for diagnostic reimbursement.
Those allegations place diagnosis coding near the center of the prosecution because insurers ordinarily rely upon submitted conditions, procedure codes, provider certifications, and supporting records when deciding whether requested examinations satisfy contractual coverage and medical-necessity requirements.
Finkelstein’s national licenses allegedly allowed the companies to place his physician identity behind claims involving athletes in multiple states, but prosecutors must establish who selected each diagnosis and whether he understood that submitted information was materially inaccurate.
Defense lawyers may argue that coders, billers, contractors, software systems, or other participants selected diagnoses without his knowledge, and that ambiguous questionnaire responses or administrative mistakes could explain at least some disputed entries without showing criminal deception.
Prosecutors will likely respond through internal communications, recurring coding patterns, denial appeals, electronic records, provider agreements, and corporate authority evidence intended to show systematic conduct rather than isolated misunderstandings within a complicated billing workflow.
Service locations allegedly misrepresented campus testing
Federal authorities further allege that claims used place-of-service information suggesting athletes underwent cardiovascular testing at Finkelstein’s Tarrant County office, even though traveling personnel had actually performed the examinations upon school campuses elsewhere.
Service location can influence licensing, network participation, reimbursement rates, supervision standards, facility requirements, patient cost sharing, and payer verification, making geographic accuracy potentially material rather than merely administrative within healthcare claims processing.
The alleged discrepancy also illustrates how Finkelstein’s licensing portfolio and centralized companies supposedly linked distant campus encounters to a Texas billing structure that could present services under his professional identity across multiple insurance markets.
Defense attorneys may argue that centralized billing rules, remote interpretation practices, claim-form conventions, reassignment arrangements, or software defaults explain particular entries, requiring payer-specific testimony before jurors can determine whether any location designation was knowingly deceptive.
The prosecution must therefore move beyond demonstrating that an athlete attended school outside Texas and establish what each disputed claim represented, what the applicable insurer expected, and why the information influenced payment decisions.
Professional companies handled nationwide claims
The government identifies Cardiovascular Testing Services PA and Cardiovascular Healthcare Associates PA as Texas professional associations owned by Finkelstein and allegedly used to submit claims, receive reimbursements, challenge denials, and distribute proceeds arising from campus testing.
Professional entities can provide lawful organizational structures for physicians serving patients across multiple jurisdictions, although prosecutors allege these companies instead concealed connections with another enterprise and allowed rejected billing activity to continue under different corporate channels.
Corporate formation records, bank accounts, enrollment applications, ownership documents, contracts, tax filings, communications, and electronic permissions may help jurors determine whether Finkelstein exercised meaningful control over nationwide operations or occupied a more limited clinical role.
The defense may emphasize that ownership establishes neither knowledge nor intent, particularly when separate managers, marketers, technicians, billers, administrators, and contractors controlled daily decisions across an organization operating at numerous schools nationwide.
Prosecutors may counter that ownership, medical-director responsibilities, provider certifications, licensing renewals, financial receipts, appeals activity, and internal messages collectively demonstrate active participation rather than professional distance from the alleged billing enterprise.
Multi-state compliance created extensive obligations
Practicing across 48 states potentially involved numerous licensing boards, renewal schedules, continuing education requirements, supervision rules, telemedicine standards, patient-record obligations, prescribing restrictions, professional disclosures, and jurisdiction-specific expectations governing physician conduct.
The government may argue that a physician sophisticated enough to maintain such an extensive licensing network would understand that geographic location, personnel qualifications, medical necessity, and provider identity mattered when claims crossed state and insurer boundaries.
That argument remains circumstantial, however, because regulatory experience does not prove awareness of inaccurate data entered by other people, nor does administrative sophistication establish that a defendant knowingly joined a criminal conspiracy.
Defense attorneys can examine whether compliance vendors, credentialing specialists, attorneys, billing companies, or corporate employees managed licensing and enrollment requirements, potentially weakening any inference that Finkelstein personally controlled every jurisdictional aspect of the enterprise.
Jurors will ultimately need to distinguish professional capacity from criminal purpose, ensuring that the remarkable scale of Finkelstein’s licensing history does not substitute for transaction-specific proof concerning knowledge, deception, and voluntary participation.
Technician credentials may complicate the licensing theory
Prosecutors also allege that traveling sonographers lacked requisite credentials when conducting cardiovascular examinations upon campuses, creating a contrast between Finkelstein’s exceptionally broad physician licensure and the disputed qualifications of personnel acquiring patient images.
A physician’s license does not necessarily authorize every technician working alongside a business, cure deficiencies within another professional’s credentials, or satisfy separate payer, accreditation, employment, and state requirements governing diagnostic image acquisition.
The government may portray that imbalance as evidence that the operation prioritized billable physician coverage while neglecting technical qualifications necessary for reliable testing, professional compliance, and appropriate patient care at individual schools.
Defense experts may explain differences among state licensure, voluntary certification, specialized registry credentials, employer preferences, and insurer participation standards, preventing a generalized allegation from implying that every technician was untrained or legally prohibited from performing ultrasound procedures.
Connecting those personnel issues to Finkelstein will require evidence showing whether his medical-director responsibilities included hiring, credential verification, technical supervision, quality assurance, protocol approval, or investigating complaints involving mobile testing teams.
Electronic review allegedly centralized medical approval
After campus examinations generated images and preliminary findings, electronic platforms allegedly allowed Finkelstein to access and approve results remotely, making his multi-state authority useful for centralized certification across the operation’s broad geographic territory.
Prosecutors accuse him of signing numerous results as normal within only seconds of accessing the files, contending that the recorded intervals were insufficient for meaningful review of complex cardiovascular images and associated patient information.
The government may combine audit logs, image counts, timestamps, user identities, preliminary interpretations, claim dates, and payment records to argue that professional approval became a rapid administrative step to support reimbursement rather than genuine medical analysis.
Defense lawyers may investigate whether preliminary review occurred through another platform, whether qualified personnel assisted with interpretations, whether duplicated images exaggerated apparent volume, or whether logged signatures represented final authorization after earlier clinical work.
Electronic speed can suggest superficial review, but prosecutors must connect those timestamps to material claim representations and fraudulent intent rather than treating rapid professional activity as automatic proof of criminal conduct.
One athlete’s death intensifies the allegations
The indictment describes an October 2024 examination involving approximately 63 images, some containing preliminary references to possible right atrial and right ventricular hypertrophy, which Finkelstein allegedly certified as normal approximately eleven seconds after accessing them.
Approximately 24 days later, the student athlete died from sudden cardiac arrest while exercising with his basketball team, creating the prosecution’s most emotionally consequential allegation and raising difficult questions involving medical interpretation, communication, causation, and patient safety.
The death does not independently prove insurance fraud, because criminal liability requires evidence that Finkelstein knowingly participated in a scheme using materially false representations to obtain money from healthcare benefit programs.
A missed abnormality could reflect negligence, professional disagreement, delegated review, incomplete information, technical limitations, or another medical failure without necessarily establishing fraudulent intent, while fraud could theoretically exist without proof that billing conduct caused the fatal outcome.
The court may therefore set careful evidentiary boundaries to ensure jurors recognize the tragedy’s importance without letting grief, anger, or hindsight replace the statutory elements governing conspiracy and healthcare fraud.
Financial scale followed geographic scale
Prosecutors allege that the operation submitted more than eighty-nine million dollars in claims between approximately January 2019 and December 2025, with insurers paying more than thirteen-point-one million dollars into accounts associated with Finkelstein’s companies.
The government separately alleges that Finkelstein received approximately one-point-one million dollars through checks and wire transfers funded by reimbursements, presenting those payments as evidence of financial benefit arising from the nationwide testing arrangement.
Submitted charges, allowed amounts, actual payments, personal compensation, intended loss, restitution, and forfeiture represent different legal and accounting measurements, meaning the largest headline figure cannot automatically be attributed to Finkelstein as personal proceeds.
Geographic expansion may nevertheless have increased the volume of available athletes, participating institutions, insurance plans, examinations, claims, denials, appeals, and reimbursements, explaining why prosecutors consider multi-state licensure central to the alleged scheme’s financial growth.
Defense attorneys may argue that payments represented legitimate professional compensation for interpretations, administrative responsibilities, consulting services, ownership distributions, or other lawful work, requiring careful tracing before jurors infer criminal motive from income alone.
Public and private insurers allegedly received claims
The indictment identifies commercial insurance plans, Medicaid programs, the Federal Employees Health Benefits Program, and the Veterans Health Administration among the benefit arrangements allegedly billed for cardiovascular testing involving athletes nationwide.
Each program may maintain different coverage rules, provider requirements, claim formats, supervision standards, medical-necessity criteria, appeal procedures, and definitions, complicating any effort to present the entire nationwide operation through a single generalized reimbursement theory.
Prosecutors may call representatives from multiple insurers to explain why Finkelstein’s licenses, provider designations, diagnoses, service locations, professional certifications, and review representations mattered when claims were processed within their respective systems.
Defense counsel can challenge whether particular payers interpreted disputed fields consistently, whether claims were denied despite alleged inaccuracies, and whether different contractual requirements undermine the government’s attempt to characterize thousands of submissions as operationally identical.
The trial will consequently require jurors to understand how a national licensing footprint interacted with a fragmented insurance landscape where legality, coverage, and materiality could vary among states, plans, patients, and procedures.
Associated Press placed licensing within broader allegations
Associated Press reporting about the national healthcare fraud crackdown described Finkelstein’s 48-state licensing as the mechanism that allegedly allowed his company to submit claims for patients across the country after technicians traveled directly to college campuses.
The report placed the prosecution within a Justice Department initiative involving 455 defendants and more than six-point-five billion dollars in allegedly fraudulent claims, although accusations against unrelated defendants cannot establish any fact within Finkelstein’s individual case.
National publicity may influence how prospective jurors initially understand the prosecution, making careful jury selection important when separating admissible evidence from enforcement announcements, news coverage, online commentary, and allegations involving other healthcare businesses.
Finkelstein remains entitled to confront witnesses, challenge expert opinions, dispute documentary evidence, contest financial calculations, and require prosecutors to establish every element of every charged offense beyond a reasonable doubt.
Neither widespread reporting nor the extraordinary geographic scope of his licenses changes the presumption of innocence, because lawful professional credentials cannot become proof of criminal conduct merely because prosecutors allege they facilitated expansion.
Conspiracy requires more than geographic capability
To prove conspiracy, prosecutors must establish that Finkelstein knowingly and voluntarily joined an unlawful agreement intended to commit healthcare fraud or wire fraud, rather than showing only that his credentials made nationwide billing technically possible.
The government may rely upon circumstantial evidence involving corporate ownership, licensing, medical-director duties, rapid approvals, disputed diagnoses, service locations, internal communications, claim appeals, technician qualifications, and financial payments to demonstrate knowledge and intent.
Defense attorneys may separate those components by arguing that different participants controlled recruitment, campus scheduling, image acquisition, coding, billing, insurer communications, credentialing, and payments without Finkelstein understanding the supposedly fraudulent features of their work.
The three substantive healthcare fraud counts additionally require evidence connecting Finkelstein with particular executions or attempted executions of the alleged scheme, preventing broad national patterns from automatically establishing guilt upon each selected transaction.
Jurors must therefore evaluate whether licensing served as an intentional instrument of deception or simply provided lawful professional capacity within organizations where other individuals allegedly made improper decisions beyond Finkelstein’s knowledge.
Trial will examine how authority actually operated
The government’s case is scheduled for jury trial beginning April 5, 2027, before United States District Judge Aileen M. Cannon in West Palm Beach, following a calendar call presently scheduled for March 30.
Witnesses may include athletes, parents, trainers, school administrators, sonographers, billers, company employees, insurers, credentialing specialists, medical experts, technology professionals, financial analysts, investigators, and alleged participants possessing different perspectives upon the operation.
Licensing records can demonstrate legal authority, but contracts, emails, policies, electronic permissions, organizational charts, payment records, and testimony will be necessary to show how Finkelstein exercised that authority in day-to-day business activities.
The defense may show that holding a license does not reveal who recruited a school, selected a test panel, entered a diagnosis, recorded a service location, verified a technician, submitted a claim, or handled an appeal.
Prosecutors will attempt to show that the separate activities formed an integrated nationwide system whose geographic reach depended on Finkelstein’s credentials and whose revenue depended on alleged misrepresentations connected to his professional identity.
Lawful mobility cannot erase licensing accountability
The prosecution illustrates principles discussed within Amicus International’s examination of legal identity-change myths, because changing a name, residence, citizenship, or lawful documentation cannot erase professional licensing histories, financial obligations, pending charges, or judicial responsibilities.
Likewise, Amicus International’s explanation of United States extradition procedures demonstrates why international relocation cannot lawfully defeat an active prosecution, conceal forfeitable assets, obstruct court supervision, or eliminate mandatory appearances established through federal orders.
Nothing within the indictment examined for this article alleges that Finkelstein attempted to flee, conceal his location, adopt another identity, violate release conditions, or misuse international mobility, making these broader observations explanatory rather than accusatory.
His extensive professional licensing history instead shows how credentials remain traceable across jurisdictions, creating records of applications, renewals, disciplinary disclosures, insurer enrollment, corporate affiliations, and official communications that can become relevant in litigation.
Lawful international planning remains available to eligible individuals, but it cannot properly be used to frustrate prosecution, mislead regulators, obscure professional conduct, interfere with witnesses, or avoid obligations arising from pending judicial proceedings.
Nationwide licensing will remain a central trial issue
For prosecutors, the 48-state licensing portfolio provides a straightforward explanation for how a Texas cardiologist allegedly supported cardiovascular testing and insurance billing involving student athletes attending schools across the continental United States.
For the defense, those same licenses may demonstrate extensive professional qualification and regulatory compliance without establishing that Finkelstein created false diagnoses, knew technician credentials were deficient, controlled disputed billing entries, or intentionally